WWells Fargo MMeta · META

Wells Fargo Lowers Meta Price Target to $640

Jul 30, 2026· 1 min read· Reproduced verbatim
Rating
Buy
Price target
$640
Previous
$835
Implied upside
+9%

Wells Fargo analyst Ken Gawrelski lowered the price target on Meta Platforms Inc.

(NASDAQ: META) to $640 (from $835) while maintaining an Overweight rating.

“Estimate internal token costs contributed roughly $2B y/y cost growth, accounting for about 40% of y/y non-GAAP R&D spending that came in above our expectations.

Beyond employee costs lapping the AI talent acquisitions of ’25 and infrastructure costs, internal token spending was listed as the 4th largest driver of OpEx growth, the first such mention in prepared cost remarks.

Token spend another factor to consider for ’27 OpEx, where we see capacity-related OpEx contributing 25pts to growth. Estimates, rating and price target.

Reduce ’27 & ’28 total revenues by 3% each, reflecting lower revenue contribution from 3p capacity resales. ’26 total revenue forecasts increased 1%.

Cut ’27 / ’28 OI estimates by 11% / 12%, given lower revenue estimates and higher OpEx forecasts, driven by R&D (token costs & model training).

Reduce ’27 / ’28 EPS estimates by 14% / 13% to $32.07 / $38.73.

Maintain Overweight rating and cut PT to $640 (prior $835) based on 20x (prior 22.5x) our ’27 EPS.”

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Share

Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.